Use of big data in drug development for precision medicine: an update.

Qian, Tongqi; Zhu, Shijia; Hoshida, Yujin

Qian, Tongqi; Zhu, Shijia; Hoshida, Yujin.

Afiliación

Qian T; Department of Genetics and Genomic Sciences and Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Zhu S; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Hoshida Y; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Expert Rev Precis Med Drug Dev ; 4(3): 189-200, 2019.

Article en En | MEDLINE | ID: mdl-31286058

Palabras clave

Big data; drug development; high-throughput screen; in silico drug discovery; machine learning; precision medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Expert Rev Precis Med Drug Dev Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google